Bimetallic nanoantenna separates colors of light
Timur Shegai
A structure that is smaller than the wavelength of visible light (390-770 nanometers) should not really be able to scatter light. But that is exactly what the new nanoantenna does. The trick employed by the Chalmers researchers is to build an antenna with an asymmetric material composition, creating optical phase shifts.
The antenna consists of two nanoparticles about 20 nanometers apart on a glass surface, one of silver and one of gold. Experiments show that the antenna scatters visible light so that red and blue colours are directed in opposite directions.
"The explanation for this exotic phenomenon is optical phase shifts," says Timur Shegai, one of the researchers behind the discovery. "The reason is that nanoparticles of gold and silver have different optical properties, in particular different plasmon resonances. Plasmon resonance means that the free electrons of the nanoparticles oscillate strongly in pace with the frequency of the light, which in turn affects the light propagation even though the antenna is so small."
The method used by the Chalmers researchers to control the light by using asymmetric material composition – such as silver and gold – is completely new. It is easy to build this kind of nanoantenna; the researchers have shown that the antennas can be fabricated densely over large areas using cheap colloidal lithography.
The research field of nanoplasmonics is a rapidly growing area, and concerns controlling how visible light behaves at the nanoscale using a variety of metal nanostructures. Scientists now have a whole new parameter – asymmetric material composition – to explore in order to control the light.
Nanoplasmonics can be applied in a variety of areas, says Mikael Käll, professor in the research group at Chalmers.
"One example is optical sensors, where you can use plasmons to build sensors which are so sensitive that they can detect much lower concentrations of toxins or signalling substances than is possible today. This may involve the detection of single molecules in a sample, for example, to diagnose diseases at an early stage, which facilitates quick initiation of treatment."
Most read news
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.